within Pharmacolibrary.Drugs.ATC.L;

model L04AG01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 40 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,
    adminCount     = 1,
    Vd             = 8e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Muromonab-CD3 is a murine monoclonal antibody directed against the CD3 receptor of human T lymphocytes, historically used to prevent and treat acute allograft rejection in organ transplantation, especially in kidney, heart, and liver transplants. It is no longer marketed in many countries and was withdrawn from most markets in recent years.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are mainly reported in adult renal transplant recipients following intravenous administration.</p><h4>References</h4><ol><li><p>Wilde, MI, &amp; Goa, KL (1996). Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection. <i>Drugs</i> 51(5) 865–894. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199651050-00010&quot;>10.2165/00003495-199651050-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8861551/&quot;>https://pubmed.ncbi.nlm.nih.gov/8861551</a></p></li><li><p>Hooks, MA, et al., &amp; Millikan, WJ (1991). Muromonab CD-3: a review of its pharmacology, pharmacokinetics, and clinical use in transplantation. <i>Pharmacotherapy</i> 11(1) 26–37. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1902291/&quot;>https://pubmed.ncbi.nlm.nih.gov/1902291</a></p></li><li><p>Swiatecka-Urban, A (2003). Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status. <i>Paediatric drugs</i> 5(10) 699–716. DOI:<a href=&quot;https://doi.org/10.2165/00148581-200305100-00005&quot;>10.2165/00148581-200305100-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14510627/&quot;>https://pubmed.ncbi.nlm.nih.gov/14510627</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L04AG01;
